Invasive Lobular Carcinoma of the Breast
📧 Sign up to get email alerts when something new happens for Invasive Lobular Carcinoma of the Breast.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors [Phase 1]
Phase I study update for the radiopharmaceutical [177Lu]Lu-DFC413 in patients with various solid tumors, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
This clinical trial update reports demographics, characteristics, and outcomes of male breast cancer patients treated at Methodist Health Sy…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
A UCSF-led clinical trial registry entry (PLUMB Registry) aims to improve survival in metastatic lobular breast cancer. The study is current…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: [68]GA-FAPI-46 PET/CT for the Diagnosis of Metastatic Lesions in Patients With Lobular Breast Cancer (ICL). [NA]
A clinical trial evaluating GA-FAPI-46 PET/CT for identifying metastatic lesions in invasive lobular carcinoma of the breast; the study is n…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers [Phase 2]
Phase 2 neoadjuvant trial evaluating neratinib for stage I-III HER2-mutated lobular breast cancer, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-01Clinical Trial Update: Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC) [Phase 2]
A Phase 2 trial of Taletrectinib for previously treated metastatic CDH1-mutated invasive lobular breast cancer has been suspended.
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer [Phase 2]
Phase 2 trial evaluating capivasertib plus fulvestrant versus fulvestrant alone in primary high-risk invasive lobular breast cancer; recruit…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer [Phase 1]
The Phase 1 trial evaluates fluciclovine and PSMA PET/CT for classification and improved staging of invasive lobular breast cancer. The stud…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE) [Phase 2]
A Phase 2 neoadjuvant study (ROSALINE) investigates targeting ROS1 in combination with endocrine therapy for invasive lobular carcinoma of t…
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
A clinical trial evaluated hypofractionated image-guided radiation therapy for patients with stage IV breast cancer. The study status is com…